Frontiers

Frontiers is an award-winning Open Science platform and leading Open Access scholarly publisher. Our mission is to make research results openly available to the world, thereby accelerating scientific and technological innovation, societal progress and economic growth. Covering more than 600 academic disciplines, our 80+ journals are led and peer-reviewed by editorial boards of over 100,000 top researchers.

Frontiers in Endocrinology publishes rigorously peer-reviewed research from basic molecular and cellular communication to clinical care, advancing our understanding of the endocrine system, and leading to novel therapies for some of the most prevalent health issues such as obesity, diabetes, reproduction and aging. Field Chief Editor Jeff M. P. Holly at the University of Bristol is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.

In today’s world, endocrinology is becoming increasingly important as it underlies many of the challenges societies face - from obesity and diabetes to reproduction, population control and aging. Endocrinology covers a broad field from basic molecular and cellular communication through to clinical care and some of the most crucial public health issues. The journal, thus, welcomes outstanding contributions in any domain of endocrinology.

Frontiers in Endocrinology is organized into 17 Specialty Sections that cover different areas of research in Endocrinology. For more information, visit https://www.frontiersin.org/jo... and follow @FrontEndocrinol on Twitter.

Editors and Journal Manager attending this meeting

Jeff M P Holly, Field Chief Editor – Frontiers in Endocrinology

Pierre De Meyts, Specialty Chief Editor, Molecular and Structural Endocrinology – Frontiers in Endocrinology

Guy Rutter, Specialty Chief Editor, Diabetes: Molecular Mechanisms - Frontiers in Endocrinology

Jared Rutter, Specialty Chief Editor, Diabetes: Molecular Mechanisms - Frontiers in Endocrinology

Katherine Samaras, Specialty Chief Editor, Obesity – Frontiers in Endocrinology

Emilie Schrepfer, Journal Manager – Frontiers in Endocrinology

Email Emilie to discuss your research: emilie.schrepfer@frontiersin.org

Frontiers highlighted Research Topics

Special 2021 Frontiers in Endocrinology Collection for the 100th Anniversary of Insulin Discovery

Led by Drs. Pierre De Meyts and Jeff M P Holly

Endocrinology and COVID- a cross-disciplinary topic

36 articles | Led by Drs. Vera Regitz-Zagrosek, Franck Mauvais-jarvis, Susanna Hofmann, Jeff M P Holly, Alexandra Kautzky-Willer and Wei Bao

Physical Activity and Type 1 Diabetes

10 articles | Led by Drs. Johan Henrik Jendle, Michael Charles Riddell and Timothy William Jones | eBook

The Role of Ceramides in Diabetes and Cardiovascular Disease

7 articles | Led by Drs. Scott A Summers and William Louis Holland

Frontiers highlighted articles

Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial | Clinical Trial

Role of Mitochondria in the Mechanism(s) of Action of Metformin | Mini Review

Evaluating All Potential Oral Complications of Diabetes Mellitus | Review

The Role of Ceramides in Insulin Resistance | Review

Endogenous Pancreatic β Cell Regeneration: A Potential Strategy for the Recovery of β Cell Deficiency in Diabetes | Review

Cytokines and Abnormal Glucose and Lipid Metabolism | Review

New Perspective in Diabetic Neuropathy: From the Periphery to the Brain, a Call for Early Detection, and Precision Medicine | Review

Exercise Management for Young People With Type 1 Diabetes: A Structured Approach to the Exercise Consultation | Review

Efficacy of Co-administration of Liuwei Dihuang Pills and Ginkgo Biloba Tablets on Albuminuria in Type 2 Diabetes: A 24-Month, Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial | Clinical Trial

Environmental Factors Associated With Type 1 Diabetes | Review

Molecular Mechanisms of Glucose Fluctuations on Diabetic Complications | Review

Impact of Nutrient Type and Sequence on Glucose Tolerance: Physiological Insights and Therapeutic Implications | MiniReview

Gaps in Knowledge and the Need for Patient-Partners in Research Related to Physical Activity and Type 1 Diabetes: A Narrative Review | Review

Mechanisms of Macrophage Polarization in Insulin Signaling and Sensitivity | Review

Why launch a Frontiers Research Topic?

Frontiers’ Research Topics are peer-reviewed article collections around cutting-edge research themes. Defined, managed and led by renowned researchers, they unite the world’s leading experts around the hottest topics, stimulating collaboration and accelerating science. Managed and disseminated on Frontiers’ Open Science platform, these collections are free to access and highly visible, increasing readership and citations for your research.

Frontiers highlights

• Gold open-access publisher
• 5th most-cited of world's 20 largest publishers
• Rigorous, constructive, efficient and transparent peer review
• Average time from submission to final decision: 90 days